1
Optimal Dosing of Omeprazole in Neonates
Condition(s):Gastroesophageal Reflux Disease (GERD)Last Updated:October 11, 2012Completed
Omeprazole: 496 Clinical Trials, Page 1 of 50
Hide Studies Not Open or Pending
2
The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and Omeprazole
Condition(s):Prostate Cancer PatientsLast Updated:December 19, 2020Recruiting
3
Oral Omeprazole in Bleeding Peptic Ulcer
Condition(s):Bleeding Peptic UlcerLast Updated:November 25, 2019Not yet recruiting
4
Prilosec Bioequivalence Study in Healthy Volunteers
Condition(s):Bioequivalence, AUC, Cmax, PharmacokineticsLast Updated:November 25, 2013Completed
5
Study to Compare the Bioavailability of Omeprazole 20 mg Before and After Undergoing Surgery for Morbid Obesity
Condition(s):Bariatric Surgery CandidateLast Updated:February 25, 2019Completed
6
Single Dose Omeprazole Versus High Dose in High-risk Critically Ill Patients.
Condition(s):Critical IllnessLast Updated:January 3, 2018Completed
7
Effect of Omeprazole on Metformin
Condition(s):HealthyLast Updated:March 19, 2013Completed
8
Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF)
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:November 20, 2017Completed
9
Effects of Different Omeprazole Dosing on Gastric pH in Non-variceal Upper Gastrointestinal Bleeding
Condition(s):Non-variceal Upper Gastrointestinal BleedingLast Updated:June 10, 2019Completed
10
Pharmacokinetic Study of the HCV Protease Inhibitor Bo-cePRevir and the Proton Pump Inhibitor OMeprazOle (PROMO)
Condition(s):HCV Infections; Gastric Acid-related DisordersLast Updated:December 1, 2020Completed